In individuals with type 1 diabetes, hypoglycemia is a common consequence of overinsulinization. Under conditions of insulin-induced hypoglycemia, glucagon is the most important stimulus for hepatic glucose production. In contrast, during euglycemia, insulin potently inhibits glucagon’s effect on the liver. The first aim of the present study was to determine whether low blood sugar augments glucagon’s ability to increase glucose production. Using a conscious catheterized dog model, we found that hypoglycemia increased glucagon’s ability to overcome the inhibitory effect of insulin on hepatic glucose production by almost 3-fold, an effect exclusively attributable to marked enhancement of the effect of glucagon on net glycogen breakdown. To investigate the molecular mechanism by which this effect comes about, we analyzed hepatic biopsies from the same animals, and found that hypoglycemia resulted in a decrease in insulin signaling. Furthermore, hypoglycemia and glucagon had an additive effect on the activation of AMPK, which was associated with altered activity of the enzymes of glycogen metabolism.
Noelia Rivera, Christopher J. Ramnanan, Zhibo An, Tiffany Farmer, Marta Smith, Ben Farmer, Jose M. Irimia, Wanda Snead, Margaret Lautz, Peter J. Roach, Alan D. Cherrington
Title and authors | Publication | Year |
---|---|---|
C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions
Mary Courtney Moore, Shana O. Warner, Yufei Dai, Nicole Sheanon, Marta Smith, Ben Farmer, Rebecca L. Cason, Alan D. Cherrington, Jason J. Winnick |
JCI Insight | 2021 |
Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia
SO Warner, AM Wadian, M Smith, B Farmer, Y Dai, N Sheanon, DS Edgerton, JJ Winnick |
American journal of physiology. Endocrinology and metabolism | 2021 |
The hepatic glucose-mobilizing effect of glucagon is not mediated by cyclic AMP most of the time
RL Rodgers |
American journal of physiology. Endocrinology and metabolism | 2021 |
Structural principles of insulin formulation and analog design: A century of innovation
MA Jarosinski, B Dhayalan, YS Chen, D Chatterjee, N Varas, MA Weiss |
Molecular Metabolism | 2021 |
Serum spexin concentration, body condition score and markers of obesity in dogs
PA Kolodziejski, E PruszynskaOszmalek, T Nowak, A Lukomska, M Sassek, J Wlodarek, L Nogowski, A Cieslak, KW Nowak |
Journal of Veterinary Internal Medicine | 2021 |
New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals
M Jarosinski, Y Chen, N Varas, B Dhayalan, D Chatterjee, M Weiss |
The Journal of clinical endocrinology and metabolism | 2021 |